NCT02414100View on ClinicalTrials.gov

Patient Derived Cancer Cell Lines in Identifying Molecular Changes in Patients With Previously Untreated Pancreatic Cancer Receiving Gemcitabine Hydrochloride-Based Chemotherapy

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

December 12, 2013

Primary Completion Date

December 15, 2016

Study Completion Date

December 15, 2016

Conditions
Pancreatic Ductal AdenocarcinomaStage IA Pancreatic CancerStage IB Pancreatic CancerStage IIA Pancreatic CancerStage IIB Pancreatic CancerStage III Pancreatic CancerStage IV Pancreatic Cancer
Interventions
OTHER

Laboratory Biomarker Analysis

Correlative studies

OTHER

Cytology Specimen Collection Procedure

Correlative studies

Trial Locations (1)

19107

Thomas Jefferson University, Philadelphia

Sponsors

Collaborators (1)

Celgene
All Listed Sponsors
collaborator

Celgene

INDUSTRY

lead

Sidney Kimmel Cancer Center at Thomas Jefferson University

OTHER